Literature DB >> 28351033

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.

Marianne Pavel1, Juan W Valle, Barbro Eriksson, Anja Rinke, Martyn Caplin, Jie Chen, Frederico Costa, Jenny Falkerby, Nicola Fazio, Vera Gorbounova, Wouter de Herder, Matthew Kulke, Catherine Lombard-Bohas, J O'Connor, Halfdan Sorbye, Rocio Garcia-Carbonero.   

Abstract

Entities:  

Year:  2017        PMID： 28351033     DOI： 10.1159/000471880

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  49 in total

Review 1.  Somatostatin receptor PET ligands - the next generation for clinical practice.

Authors:  Elin Pauwels; Frederik Cleeren; Guy Bormans; Christophe M Deroose
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-10-20

Review 2.  Management of functional neuroendocrine tumors of the pancreas.

Authors:  Kjell Öberg
Journal:  Gland Surg       Date:  2018-02

3.  Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.

Authors:  Nicole Brighi; Francesco Panzuto; Roberta Modica; Fabio Gelsomino; Manuela Albertelli; Sara Pusceddu; Sara Massironi; Giuseppe Lamberti; Maria Rinzivillo; Antongiulio Faggiano; Andrea Spallanzani; Diego Ferone; Natalie Prinzi; Roberta Elisa Rossi; Bruno Annibale; Anna Maria Colao; Davide Campana
Journal:  Oncologist       Date:  2019-11-06

Review 4.  Nutrition and neuroendocrine tumors: An update of the literature.

Authors:  Barbara Altieri; Luigi Barrea; Roberta Modica; Giovanna Muscogiuri; Silvia Savastano; Annamaria Colao; Antongiulio Faggiano
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 5.  Update in the Therapy of Advanced Neuroendocrine Tumors.

Authors:  Inbal Uri; Shani Avniel-Polak; David J Gross; Simona Grozinsky-Glasberg
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

Review 6.  The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Fabiola Amair-Pinedo; Ignacio Matos; Tamara Saurí; Jorge Hernando; Jaume Capdevila
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493

7.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

8.  Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.

Authors:  Nicole Brighi; Francesco Panzuto; Roberta Modica; Fabio Gelsomino; Manuela Albertelli; Sara Pusceddu; Sara Massironi; Giuseppe Lamberti; Maria Rinzivillo; Antongiulio Faggiano; Andrea Spallanzani; Diego Ferone; Natalie Prinzi; Roberta Elisa Rossi; Bruno Annibale; Anna Maria Colao; Davide Campana
Journal:  Oncologist       Date:  2019-11-06

Review 9.  Carcinoid Syndrome: Updates and Review of Current Therapy.

Authors:  Kira Oleinikov; Shani Avniel-Polak; David J Gross; Simona Grozinsky-Glasberg
Journal:  Curr Treat Options Oncol       Date:  2019-07-09

Review 10.  Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.

Authors:  Xi-Feng Jin; Matilde P Spampatti; Christine Spitzweg; Christoph J Auernhammer
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.